Surgical resection after imatinib treatment in patients with metastatic or unresectable gastrointestinal stromal tumors

被引：0

作者：

Ryu, Min-Hee ^{[1
]}

Lee, Jae-Lyun ^{[1
]}

Chang, Heung Moon ^{[1
]}

Kim, Tae Won ^{[1
]}

Kim, Hee Cheol ^{[1
]}

Yook, Jeong Hwan ^{[1
]}

Yu, Chang Sik ^{[1
]}

Kim, Byung Sik ^{[1
]}

Kim, Jin Cheon ^{[1
]}

Kang, Yoon-Koo ^{[1
]}

机构：

[1] Asan Med Ctr, Div Oncol, Seoul, South Korea

来源：

ANNALS OF ONCOLOGY | 2006年 / 17卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：164 / 164

页数：1

共 50 条

[1] Surgical resection of gastrointestinal stromal tumors after treatment with imatinib
Andtbacka, RH
Cormier, JN
Scaife, CL
Hunt, KK
Pisters, PW
Pollock, RE
Benjamin, RS
Burgess, MA
Chen, LL
Feig, BW
[J]. ANNALS OF SURGICAL ONCOLOGY, 2005, 12 (02) : S35 - S35
[2] Surgical Resection of Gastrointestinal Stromal Tumors After Treatment with Imatinib
Robert H. I. Andtbacka
Chaan S. Ng
Courtney L. Scaife
Janice N. Cormier
Kelly K. Hunt
Peter W. T. Pisters
Raphael E. Pollock
Robert S. Benjamin
Michael A. Burgess
Lei L. Chen
Jonathan Trent
Shreyaskumar R. Patel
Kevin Raymond
Barry W. Feig
[J]. Annals of Surgical Oncology, 2007, 14 : 14 - 24
[3] Surgical resection of gastrointestinal stromal tumors after treatment with imatinib
Andtbacka, Robert H. I.
Ng, Chaan S.
Scaife, Courtney L.
Cormier, Janice N.
Hunt, Kelly K.
Pisters, Peter W. T.
Pollock, Raphael E.
Benjamin, Robert S.
Burgess, Michael A.
Chen, Lei L.
Trent, Jonathan
Patel, Shreyaskumar R.
Raymond, Kevin
Feig, Barry W.
[J]. ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (01) : 14 - 24
[4] Resection of residual disease in patients with metastatic gastrointestinal stromal tumors responding to treatment with imatinib
Bauer, S
Hartmann, JT
de Wit, M
Lang, H
Grabellus, F
Antoch, G
Niebel, W
Erhard, J
Ebeling, P
Zeth, M
Taeger, G
Seeber, S
Flasshove, M
Schütte, J
[J]. INTERNATIONAL JOURNAL OF CANCER, 2005, 117 (02) : 316 - 325
[5] Surgical resection in metastatic gastrointestinal stromal tumors
Choi E.A.
Feig B.W.
[J]. Current Oncology Reports, 2007, 9 (4) : 303 - 308
[6] Approval summary: Imatinib mesylate in the treatment of metastatic and/or unresectable malignant gastrointestinal stromal tumors
Dagher, R
Cohen, M
Williams, G
Rothmann, M
Gobburu, J
Robbie, G
Rahman, A
Chen, G
Staten, A
Griebel, D
Pazdur, R
[J]. CLINICAL CANCER RESEARCH, 2002, 8 (10) : 3034 - 3038
[7] Approval Summary: Imatinib Mesylate in the Treatment of Metastatic and/or Unresectable Malignant Gastrointestinal Stromal Tumors
Cohen, Martin H.
Farrell, Ann
Justice, Robert
Pazdur, Richard
[J]. ONCOLOGIST, 2009, 14 (02): : 174 - 180
[8] The Role of Surgical Resection Following Imatinib Treatment in Patients with Recurrent or Metastatic Gastrointestinal Stromal Tumors: Results of Propensity Score Analyses
Park, Seong Joon
Ryu, Min-Hee
Ryoo, Baek-Yeol
Park, Young Soo
Sohn, Byeong Seok
Kim, Hwa Jung
Kim, Chan Wook
Kim, Ki-Hun
Yu, Chang Sik
Yook, Jeong Hwan
Kim, Byung Sik
Kang, Yoon-Koo
[J]. ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (13) : 4211 - 4217
[9] The Role of Surgical Resection Following Imatinib Treatment in Patients with Recurrent or Metastatic Gastrointestinal Stromal Tumors: Results of Propensity Score Analyses
Seong Joon Park
Min-Hee Ryu
Baek-Yeol Ryoo
Young Soo Park
Byeong Seok Sohn
Hwa Jung Kim
Chan Wook Kim
Ki-Hun Kim
Chang Sik Yu
Jeong Hwan Yook
Byung Sik Kim
Yoon-Koo Kang
[J]. Annals of Surgical Oncology, 2014, 21 : 4211 - 4217
[10] Prognostic factors after imatinib secondary resistance: survival analysis in patients with unresectable and metastatic gastrointestinal stromal tumors
Kanda, Tatsuo
Ishikawa, Takashi
Kosugi, Shin-ichi
Ueki, Kyo
Naito, Tetsuya
Wakai, Toshifumi
Hirota, Seiichi
[J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2016, 21 (02) : 295 - 301

← 1 2 3 4 5 →